Grants per year
Personal profile
Education/Academic qualification
Medicine, MD, University of Chicago
… → 1981
Fingerprint
Dive into the research topics where Stephanie Francesca Williams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Prot# B9E-US-X446: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)
Gordon, L. I., Gordon, L. I., Kuzel, T. M., Mehta, J., Platanias, L. C., Singhal, S., Williams, S. F. & Winter, J. N.
9/12/05 → 10/31/17
Project: Research project
-
Prot# VEL-03-082: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)
Gordon, L. I., Gordon, L. I., Kuzel, T. M., Mehta, J., Platanias, L. C., Singhal, S., Williams, S. F. & Winter, J. N.
Millennium Pharmaceuticals, Inc
7/8/05 → 10/31/14
Project: Research project
-
Prot# NU 03Z2: Prospective Fertility Assessment for Men and Women Receiving 90Yttrium-Zevalin Therapy
Brannigan, R. E., Singhal, S., Spies, S. M., Williams, S. F., Winter, J. N. & Woodruff, T. K.
5/24/04 → 6/26/07
Project: Research project
-
Prot# NU 02H8 (PCYC-0213): A Phase I/II Trial of Redox Regulation in Patients with Relapsed or Refractory CD20 Positive Non-Hodgkin's Lymphoma (NHL) Combining 90-Yttrium-Zevalin® and the Redox-Modulating Agent, Motexafin Gadolinium (MGd) (Prot# 106-P115)
Gordon, L. I., Kuzel, T. M., Singhal, S., Spies, S. M., Williams, S. F. & Winter, J. N.
9/5/03 → 1/1/11
Project: Research project
-
Prot# NU 02H8 (PCYC-0213): A Phase I/II Trial of Redox Regulation in Patients with Relapsed or Refractory CD20 Positive Non-Hodgkin's Lymphoma (NHL): Combining 90Yttrium-Zevalin & Redox-Modulating Agent, Motexafin Gadolinium (MGd)
Gordon, L. I., Kuzel, T. M., Singhal, S., Spies, S. M., Williams, S. F. & Winter, J. N.
7/23/03 → 9/1/11
Project: Research project
-
Effect of Physical Condition on Outcomes in Transplant Patients: A Retrospective Data Analysis
Andres, K., Wayman, B., Rodriguez, T., Kline, M., Haveman, J., Brower, C. & Williams, S. F., Jul 1 2020, In: Rehabilitation Oncology. 38, 3, p. 116-121 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Calcineurin and mTOR Inhibitor–Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study
Al-Homsi, A. S., Cole, K., Muilenburg, M., Goodyke, A., Abidi, M., Duffner, U., Williams, S., Parker, J. & Abdel-Mageed, A., Oct 2017, In: Biology of Blood and Marrow Transplantation. 23, 10, p. 1651-1657 7 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Adverse events during hematopoietic stem cell infusion: Analysis of the infusion product
Vidula, N., Villa, M., Helenowski, I. B., Merchant, M., Jovanovic, B. D., Meagher, R., Mehta, J., Singhal, S., Winter, J. N., Frankfurt, O., Altman, J. K., Williams, S. F. & Gordon, L. I., Nov 2015, In: Clinical Lymphoma, Myeloma and Leukemia. 15, 11, p. e157-e162Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study
Al-Homsi, A. S., Cole, K., Bogema, M., Duffner, U., Williams, S. & Mageed, A., Jul 1 2015, In: Biology of Blood and Marrow Transplantation. 21, 7, p. 1315-1320 6 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
Gentzler, R. D., Evens, A. M., Rademaker, A. W., Weitner, B. B., Mittal, B. B., Dillehay, G. L., Petrich, A. M., Altman, J. K., Frankfurt, O., Variakojis, D., Singhal, S., Mehta, J., Williams, S., Kaminer, L., Gordon, L. I. & Winter, J. N., Jun 2014, In: British Journal of Haematology. 165, 6, p. 793-800 8 p.Research output: Contribution to journal › Article › peer-review
36 Scopus citations